BDNF and hyperinsulinemic hypoglycemia, familial, 4: Given that neurotrophin deficiency and dysregulation is closely associated with the pathogenesis of AD [38], supplementation of neurotrophic factors (nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF)) is currently a potential therapeutic approach to treat AD [27].